Pharmacokinetics of Neostigmine and Glycopyrrolate
common.study.values.description
“Pharmacokinetics of Neostigmine and Glycopyrrolate”
A group of 6 able-bodied healthy volunteers will receive Neostigmine (NEO) and Glycopyrrolate (GLY) intravenously and via 3 different methods of Iontophoresis (ION) with subsequent blood draws over 1 hour in order to measure the pharmacokinetic behavior of the drugs en-vivo.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Drug - Combination of Neostigmine and Glycopyrrolate
Intravenous or transdermal
Device - I-Box by Dynatronics
Electric field conducting drugs through the skin without compromising its integrity
participant.views.study.view.additional
participant.views.study.view.scientific-title
Pharmacokinetics of Neostigmine and Glycopyrrolate After Intravenous and Transcutaneous Administration by Iontophoresis
common.study.values.clinical-trial-id
NCT04027972
participant.views.study.view.id
eZ6xwe